36C26322Q0059.docx
DOCX document 157 KB Posted
- Attached to
- 6505--Radiopharmaceuticals (Omaha, NE)
- Solicitation number
- 36C26322Q0059
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
36C26322Q0059
PAGE 1 OF
1. REQUISITION NO.
2. CONTRACT NO.
3. AWARD/EFFECTIVE DATE
4. ORDER NO.
5. SOLICITATION NUMBER
6. SOLICITATION ISSUE DATE
a. NAME
b. TELEPHONE NO. (No Collect Calls)
8. OFFER DUE DATE/LOCAL
TIME
9. ISSUED BY
CODE
10. THIS ACQUISITION IS
UNRESTRICTED OR
SET ASIDE:
% FOR:
SMALL BUSINESS
HUBZONE SMALL
BUSINESS
SERVICE-DISABLED
VETERAN-OWNED
SMALL BUSINESS
WOMEN-OWNED SMALL BUSINESS
(WOSB) ELIGIBLE UNDER THE WOMEN-OWNED
SMALL BUSINESS PROGRAM
EDWOSB
8(A)
NAICS:
SIZE STANDARD:
11. DELIVERY FOR FOB DESTINA-
TION UNLESS BLOCK IS
MARKED
SEE SCHEDULE
12. DISCOUNT TERMS
13a. THIS CONTRACT IS A
RATED ORDER UNDER
DPAS (15 CFR 700)
13b. RATING
14. METHOD OF SOLICITATION
RFQ
IFB
RFP
15. DELIVER TO
CODE
16. ADMINISTERED BY
CODE
17a. CONTRACTOR/OFFEROR
CODE
FACILITY CODE
18a. PAYMENT WILL BE MADE BY
CODE
TELEPHONE NO.
DUNS:
DUNS+4:
PHONE:
FAX:
17b. CHECK IF REMITTANCE IS DIFFERENT AND PUT SUCH ADDRESS IN OFFER 18b. SUBMIT INVOICES TO ADDRESS SHOWN IN BLOCK 18a UNLESS BLOCK BELOW IS CHECKED
SEE ADDENDUM
19.
20.
21.
22.
23.
24.
ITEM NO.
SCHEDULE OF SUPPLIES/SERVICES
QUANTITY
UNIT
UNIT PRICE
AMOUNT
(Use Reverse and/or Attach Additional Sheets as Necessary)
25. ACCOUNTING AND APPROPRIATION DATA
26. TOTAL AWARD AMOUNT (For Govt. Use Only) 27a. SOLICITATION INCORPORATES BY REFERENCE FAR 52.212-1, 52.212-4. FAR 52.212-3 AND 52.212-5 ARE ATTACHED. ADDENDA
ARE
ARE NOT ATTACHED.
27b. CONTRACT/PURCHASE ORDER INCORPORATES BY REFERENCE FAR 52.212-4. FAR 52.212-5 IS ATTACHED. ADDENDA
ARE
ARE NOT ATTACHED
28. CONTRACTOR IS REQUIRED TO SIGN THIS DOCUMENT AND RETURN _______________
29. AWARD OF CONTRACT: REF. ___________________________________ OFFER
COPIES TO ISSUING OFFICE. CONTRACTOR AGREES TO FURNISH AND
DATED ________________________________. YOUR OFFER ON SOLICITATION
DELIVER ALL ITEMS SET FORTH OR OTHERWISE IDENTIFIED ABOVE AND ON ANY
(BLOCK 5), INCLUDING ANY ADDITIONS OR CHANGES WHICH ARE
ADDITIONAL SHEETS SUBJECT TO THE TERMS AND CONDITIONS SPECIFIED
SET FORTH HEREIN IS ACCEPTED AS TO ITEMS:
30a. SIGNATURE OF OFFEROR/CONTRACTOR 31a. UNITED STATES OF AMERICA (SIGNATURE OF CONTRACTING OFFICER) 30b. NAME AND TITLE OF SIGNER (TYPE OR PRINT) 30c. DATE SIGNED 31b. NAME OF CONTRACTING OFFICER (TYPE OR PRINT) 31c. DATE SIGNED
AUTHORIZED FOR LOCAL REPRODUCTION
(REV. 2/2012)
PREVIOUS EDITION IS NOT USABLE
Prescribed by GSA - FAR (48 CFR) 53.212
7. FOR SOLICITATION
INFORMATION CALL:
STANDARD FORM 1449
OFFEROR TO COMPLETE BLOCKS 12, 17, 23, 24, & 30
SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL ITEMS
36C26322Q0059 11- -2021 Andrea Harter andrea.harter@va.gov 320-654-7616 11-23-2021
10:00 AM
CST
Department of Veterans Affairs
NETWORK 23 CONTRACTING OFFICE
Contract Officer 4801 Veterans Drive St. Cloud MN 56303 X 325412 1250 Employees N/A X Department of Veterans Affairs NWI VA Health Care System 4101 Woolworth Ave Omaha NE 68105 Same as Issued By
Department of Veterans Affairs Financial Service Center PO Box 149971 Austin TX 78714 512-460-5540 See CONTINUATION Page Radiopharmaceuticals See Attached Price/Cost Schedule **Offerors are asked to also complete the table in Section D as part their response in order to comply with the VA's Supply Chain Master Catalog.
Ordering Period 1: 1/1/2022 to 9/30/2022 Ordering Period 2: 10/1/2022 to 9/30/2023 Ordering Period 3: 10/1/2023 to 9/30/2024 Ordering Period 4: 10/1/2024 to 9/30/2025 Ordering Period 5: 10/1/2025 to 9/30/2026 Ordering Period 6: 10/1/2026 to 12/31/2026 See CONTINUATION Page As Cited on Each Delivery Order X X Andrea Harter Table of Contents
| SECTION A | 1 |
| A.1 SF 1449 SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL ITEMS | 1 |
| SECTION B - CONTINUATION OF SF 1449 BLOCKS | 3 |
| B.1 CONTRACT ADMINISTRATION DATA | 3 |
| B.2 PRICE/COST SCHEDULE | 3 |
| ITEM INFORMATION | 3 |
| Indefinite Delivery Indefinite Quantity (IDIQ) Ceiling Limitation and Minimum Guarantee | 37 |
| **Note on the Price/Cost Schedule | 37 |
| B.3 STATEMENT OF WORK | 38 |
| SECTION C - CONTRACT CLAUSES | 43 |
| C.1 52.252-2 CLAUSES INCORPORATED BY REFERENCE (FEB 1998) | 43 |
| C.2 52.216-18 ORDERING (AUG 2020) | 43 |
| C.3 52.216-19 ORDER LIMITATIONS (OCT 1995) | 44 |
| C.4 52.216-22 INDEFINITE QUANTITY (OCT 1995) | 44 |
| C.5 52.232-19 AVAILABILITY OF FUNDS FOR THE NEXT FISCAL YEAR (APR 1984) | 46 |
| C.6 VAAR 852.242-71 ADMINISTRATIVE CONTRACTING OFFICER (OCT 2020) | 46 |
| C.7 52.212-5 CONTRACT TERMS AND CONDITIONS REQUIRED TO IMPLEMENT STATUTES OR EXECUTIVE ORDERS—COMMERCIAL ITEMS (JAN 2021) (JUL 2020) (DEVIATION) | 47 |
| SECTION D - CONTRACT DOCUMENTS, EXHIBITS, OR ATTACHMENTS | 55 |
| SECTION E - SOLICITATION PROVISIONS | 58 |
| E.1 52.252-1 SOLICITATION PROVISIONS INCORPORATED BY REFERENCE (FEB 1998) | 58 |
| E.2 52.204-24 REPRESENTATION REGARDING CERTAIN TELECOMMUNICATIONS AND VIDEO SURVEILLANCE SERVICES OR EQUIPMENT (OCT 2020) | 58 |
| E.3 52.209-7 INFORMATION REGARDING RESPONSIBILITY MATTERS (OCT 2018) | 61 |
| E.4 52.233-2 SERVICE OF PROTEST (SEP 2006) | 62 |
| E.5 52.212-2 EVALUATION—COMMERCIAL ITEMS (JAN 1999) | 63 |
| E.6 52.212-3 OFFEROR REPRESENTATIONS AND CERTIFICATIONS—COMMERCIAL ITEMS (FEB 2021) (JUL 2020) (DEVIATION) | 64 |
SECTION B - CONTINUATION OF SF 1449 BLOCKS
B.1 CONTRACT ADMINISTRATION DATA
1. Contract Administration: All contract administration matters will be handled by the following individuals:
a. CONTRACTOR:
b. GOVERNMENT: Contracting Officer 36C263 Department of Veterans Affairs
NETWORK 23 CONTRACTING OFFICE
Contract Officer 4801 Veterans Drive St. Cloud MN 56303
2. CONTRACTOR REMITTANCE ADDRESS: All payments by the Government to the contractor will be made in accordance with:
| [X] |
| 52.232-33, Payment by Electronic Funds Transfer—System For Award Management, or |
| [] |
| 52.232-36, Payment by Third Party |
3. INVOICES: Invoices shall be submitted in arrears:
| a. Quarterly | [] |
| b. Semi-Annually | [] |
| c. Other | [X] Monthly |
4. GOVERNMENT INVOICE ADDRESS: All Invoices from the contractor shall be submitted electronically in accordance with VAAR Clause 852.232-72 Electronic Submission of Payment Requests.
Department of Veterans Affairs Financial Service Center PO Box 149971 Austin TX 78714 ACKNOWLEDGMENT OF AMENDMENTS: The offeror acknowledges receipt of amendments to the Solicitation numbered and dated as follows:
| AMENDMENT NO |
| DATE |
B.2 PRICE/COST SCHEDULE
ITEM INFORMATION
| ITEM NUMBER |
| DESCRIPTION OF SUPPLIES/SERVICES |
| QUANTITY |
| UNIT |
| UNIT PRICE |
| AMOUNT |
| 11.00 |
| EA |
| __________________ |
| __________________ |
Tc-99m Sestamibi, generic Contract Period: Option 1 POP Begin: 01-01-2022 POP End: 09-30-2022 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals
| 699.00 |
| EA |
| __________________ |
| __________________ |
Tc-99m Tetrofosmin
POP Begin: 01-01-2022 POP End: 09-30-2022
| 1.00 |
| EA |
| __________________ |
| __________________ |
Thallous Chloride
POP Begin: 01-01-2022 POP End: 09-30-2022
| 1.00 |
| EA |
| __________________ |
| __________________ |
Tc-99m Exametazime Brain
POP Begin: 01-01-2022 POP End: 09-30-2022
| 6.00 |
| EA |
| __________________ |
| __________________ |
Tc-99m Pentetate Aerosol
POP Begin: 01-01-2022 POP End: 09-30-2022
| 11.00 |
| EA |
| __________________ |
| __________________ |
Tc-99 Macro Aggregated
POP Begin: 01-01-2022 POP End: 09-30-2022
| 113.00 |
| EA |
| __________________ |
| __________________ |
Tc-99m Medronate
POP Begin: 01-01-2022 POP End: 09-30-2022
| 49.00 |
| EA |
| __________________ |
| __________________ |
Tc-99m Mebrofenin
POP Begin: 01-01-2022 POP End: 09-30-2022
| 15.00 |
| EA |
| __________________ |
| __________________ |
Tc-99m Mertiatide
POP Begin: 01-01-2022 POP End: 09-30-2022
| 1.00 |
| EA |
| __________________ |
| __________________ |
Tc-99m Bicisate
POP Begin: 01-01-2022 POP End: 09-30-2022
| 8.00 |
| EA |
| __________________ |
| __________________ |
Tc-99m NaTcO4 Unit Dose
POP Begin: 01-01-2022 POP End: 09-30-2022
| 1.00 |
| EA |
| __________________ |
| __________________ |
Tc-99m NaTcO4 Multi Dose
POP Begin: 01-01-2022 POP End: 09-30-2022
| 53.00 |
| EA |
| __________________ |
| __________________ |
Tc-99m Sulfur Colloid
POP Begin: 01-01-2022 POP End: 09-30-2022
| 3.00 |
| EA |
| __________________ |
| __________________ |
Tc-99m Filtered Sulfur Colloid
POP Begin: 01-01-2022 POP End: 09-30-2022
| 1.00 |
| EA |
| __________________ |
| __________________ |
Tc-99m Pyrophosphate UD - Dose up to 30mCi
POP Begin: 01-01-2022 POP End: 09-30-2022
| 1.00 |
| EA |
| __________________ |
| __________________ |
Tc-99m Exametazime UD - Dose up to 30mCi
POP Begin: 01-01-2022 POP End: 09-30-2022
| 2.00 |
| EA |
| __________________ |
| __________________ |
Tc-99m Exametazime WBC's - Dose up to 25mCi
POP Begin: 01-01-2022 POP End: 09-30-2022
| 11.00 |
| EA |
| __________________ |
| __________________ |
Tc-99m Cardioloite UD - Dose up to 30mCi
POP Begin: 01-01-2022 POP End: 09-30-2022
| 2.00 |
| EA |
| __________________ |
| __________________ |
Tc-99m Succimer UD
POP Begin: 01-01-2022 POP End: 09-30-2022
| 23.00 |
| EA |
| __________________ |
| __________________ |
I-123 USP NaI 200 uCi Cap
POP Begin: 01-01-2022 POP End: 09-30-2022
| 1.00 |
| EA |
| __________________ |
| __________________ |
I-123 USP Nal Sol - Dose up to 30mCi
POP Begin: 01-01-2022 POP End: 09-30-2022
| 1.00 |
| EA |
| __________________ |
| __________________ |
I-123 Iobenguane Sulfate UD - Dose
POP Begin: 01-01-2022 POP End: 09-30-2022
| 1.00 |
| EA |
| __________________ |
| __________________ |
I-131 Drax DX/TX Capsule 1-6 mCi
POP Begin: 01-01-2022 POP End: 09-30-2022
| 26.00 |
| EA |
| __________________ |
| __________________ |
I-131 Drax DX/TX Capsule each add'l mCi
POP Begin: 01-01-2022 POP End: 09-30-2022
| 1.00 |
| EA |
| __________________ |
| __________________ |
In-111 Pentetreotide
POP Begin: 01-01-2022 POP End: 09-30-2022
| 2.00 |
| EA |
| __________________ |
| __________________ |
In-111 Autologous WBC Suspension - Dose up to 500uCi
POP Begin: 01-01-2022 POP End: 09-30-2022
| 8.00 |
| EA |
| __________________ |
| __________________ |
Ultra Tag RBC
POP Begin: 01-01-2022 POP End: 09-30-2022
| 2.00 |
| EA |
| __________________ |
| __________________ |
Sincalided Unit Dose
POP Begin: 01-01-2022 POP End: 09-30-2022
| 5.00 |
| EA |
| __________________ |
| __________________ |
F-18 FDG Unit Dose 0-15 mCi
POP Begin: 01-01-2022 POP End: 09-30-2022
| 338.00 |
| EA |
| __________________ |
| __________________ |
F-18 FDG UD Source
POP Begin: 01-01-2022 POP End: 09-30-2022
| 1.00 |
| EA |
| __________________ |
| __________________ |
F-18 NaF UD
POP Begin: 01-01-2022 POP End: 09-30-2022
| 2.00 |
| EA |
| __________________ |
| __________________ |
Computer Software Fee
POP Begin: 01-01-2022 POP End: 09-30-2022
| 1.00 |
| EA |
| __________________ |
| __________________ |
Computer Software Training Fee - Per Site (one time charge plus any additional required for future software updates)
POP Begin: 01-01-2022 POP End: 09-30-2022
| 3.00 |
| EA |
| __________________ |
| __________________ |
Quarterly Audits - 1 location (Omaha)
POP Begin: 01-01-2022 POP End: 09-30-2022
| 195.00 |
| EA |
| __________________ |
| __________________ |
Daily Delivery Fee
POP Begin: 01-01-2022 POP End: 09-30-2022
| 4.00 |
| EA |
| __________________ |
| __________________ |
Pharmacist After Hours Callout
POP Begin: 01-01-2022 POP End: 09-30-2022
| 8.00 |
| EA |
| __________________ |
| __________________ |
STAT Delivery
POP Begin: 01-01-2022 POP End: 09-30-2022
| 1.00 |
| EA |
| __________________ |
| __________________ |
GA-67 Gallium Citrate UD - per mCi
POP Begin: 01-01-2022 POP End: 09-30-2022
| 15.00 |
| EA |
| __________________ |
| __________________ |
Lymphoseek Study Dose - per patient
POP Begin: 01-01-2022 POP End: 09-30-2022
| 75.00 |
| EA |
| __________________ |
| __________________ |
GA-68 PMSA
POP Begin: 01-01-2022 POP End: 09-30-2022
15.00
| __________________ |
| __________________ |
Tc-99m Sestamibi, generic Contract Period: Option 2 POP Begin: 10-01-2022 POP End: 09-30-2023
932.00
| __________________ |
| __________________ |
Tc-99m Tetrofosmin
POP Begin: 10-01-2022 POP End: 09-30-2023
1.00
| __________________ |
| __________________ |
Thallous Chloride
POP Begin: 10-01-2022 POP End: 09-30-2023
1.00
| __________________ |
| __________________ |
Tc-99m Exametazime Brain
POP Begin: 10-01-2022 POP End: 09-30-2023
8.00
| __________________ |
| __________________ |
Tc-99m Pentetate Aerosol
POP Begin: 10-01-2022 POP End: 09-30-2023
15.00
| __________________ |
| __________________ |
Tc-99 Macro Aggregated
POP Begin: 10-01-2022 POP End: 09-30-2023
150.00
| __________________ |
| __________________ |
Tc-99m Medronate
POP Begin: 10-01-2022 POP End: 09-30-2023
65.00
| __________________ |
| __________________ |
Tc-99m Mebrofenin
POP Begin: 10-01-2022 POP End: 09-30-2023
20.00
| __________________ |
| __________________ |
Tc-99m Mertiatide
POP Begin: 10-01-2022 POP End: 09-30-2023
1.00
| __________________ |
| __________________ |
Tc-99m Bicisate
POP Begin: 10-01-2022 POP End: 09-30-2023
10.00
| __________________ |
| __________________ |
Tc-99m NaTcO4 Unit Dose
POP Begin: 10-01-2022 POP End: 09-30-2023
1.00
| __________________ |
| __________________ |
Tc-99m NaTcO4 Multi Dose
POP Begin: 10-01-2022 POP End: 09-30-2023
70.00
| __________________ |
| __________________ |
Tc-99m Sulfur Colloid
POP Begin: 10-01-2022 POP End: 09-30-2023
4.00
| __________________ |
| __________________ |
Tc-99m Filtered Sulfur Colloid
POP Begin: 10-01-2022 POP End: 09-30-2023
1.00
| __________________ |
| __________________ |
Tc-99m Pyrophosphate UD - Dose up to 30mCi
POP Begin: 10-01-2022 POP End: 09-30-2023
1.00
| __________________ |
| __________________ |
Tc-99m Exametazime UD - Dose up to 30mCi
POP Begin: 10-01-2022 POP End: 09-30-2023
2.00
| __________________ |
| __________________ |
Tc-99m Exametazime WBC's - Dose up to 25mCi
POP Begin: 10-01-2022 POP End: 09-30-2023
15.00
| __________________ |
| __________________ |
Tc-99m Cardioloite UD - Dose up to 30mCi
POP Begin: 10-01-2022 POP End: 09-30-2023
2.00
| __________________ |
| __________________ |
Tc-99m Succimer UD
POP Begin: 10-01-2022 POP End: 09-30-2023
30.00
| __________________ |
| __________________ |
I-123 USP NaI 200 uCi Cap
POP Begin: 10-01-2022 POP End: 09-30-2023
1.00
| __________________ |
| __________________ |
I-123 USP Nal Sol - Dose up to 30mCi
POP Begin: 10-01-2022 POP End: 09-30-2023
1.00
| __________________ |
| __________________ |
I-123 Iobenguane Sulfate UD - Dose
POP Begin: 10-01-2022 POP End: 09-30-2023
1.00
| __________________ |
| __________________ |
I-131 Drax DX/TX Capsule 1-6 mCi
POP Begin: 10-01-2022 POP End: 09-30-2023
35.00
| __________________ |
| __________________ |
I-131 Drax DX/TX Capsule each add'l mCi
POP Begin: 10-01-2022 POP End: 09-30-2023
1.00
| __________________ |
| __________________ |
In-111 Pentetreotide
POP Begin: 10-01-2022 POP End: 09-30-2023
2.00
| __________________ |
| __________________ |
In-111 Autologous WBC Suspension - Dose up to 500uCi
POP Begin: 10-01-2022 POP End: 09-30-2023
10.00
| __________________ |
| __________________ |
Ultra Tag RBC
POP Begin: 10-01-2022 POP End: 09-30-2023
3.00
| __________________ |
| __________________ |
Sincalided Unit Dose
POP Begin: 10-01-2022 POP End: 09-30-2023
6.00
| __________________ |
| __________________ |
F-18 FDG Unit Dose 0-15 mCi
POP Begin: 10-01-2022 POP End: 09-30-2023
450.00
| __________________ |
| __________________ |
F-18 FDG UD Source
POP Begin: 10-01-2022 POP End: 09-30-2023
1.00
| __________________ |
| __________________ |
F-18 NaF UD
POP Begin: 10-01-2022 POP End: 09-30-2023
3.00
| __________________ |
| __________________ |
Computer Software Fee
POP Begin: 10-01-2022 POP End: 09-30-2023
1.00
| __________________ |
| __________________ |
Computer Software Training Fee - Per Site (one time charge plus any additional required for future software updates)
POP Begin: 10-01-2022 POP End: 09-30-2023
4.00
| __________________ |
| __________________ |
Quarterly Audits - 1 location (Omaha)
POP Begin: 10-01-2022 POP End: 09-30-2023
260.00
| __________________ |
| __________________ |
Daily Delivery Fee
POP Begin: 10-01-2022 POP End: 09-30-2023
5.00
| __________________ |
| __________________ |
Pharmacist After Hours Callout
POP Begin: 10-01-2022 POP End: 09-30-2023
10.00
| __________________ |
| __________________ |
STAT Delivery
POP Begin: 10-01-2022 POP End: 09-30-2023
1.00
| __________________ |
| __________________ |
GA-67 Gallium Citrate UD - per mCi
POP Begin: 10-01-2022 POP End: 09-30-2023
20.00
| __________________ |
| __________________ |
Lymphoseek Study Dose - per patient
POP Begin: 10-01-2022 POP End: 09-30-2023
100.00
| __________________ |
| __________________ |
GA-68 PMSA
POP Begin: 10-01-2022 POP End: 09-30-2023
15.00
| __________________ |
| __________________ |
Tc-99m Sestamibi, generic Contract Period: Option 3 POP Begin: 10-01-2023 POP End: 09-30-2024
932.00
| __________________ |
| __________________ |
Tc-99m Tetrofosmin
POP Begin: 10-01-2023 POP End: 09-30-2024
1.00
| __________________ |
| __________________ |
Thallous Chloride
POP Begin: 10-01-2023 POP End: 09-30-2024
1.00
| __________________ |
| __________________ |
Tc-99m Exametazime Brain
POP Begin: 10-01-2023 POP End: 09-30-2024
8.00
| __________________ |
| __________________ |
Tc-99m Pentetate Aerosol
POP Begin: 10-01-2023 POP End: 09-30-2024
15.00
| __________________ |
| __________________ |
Tc-99 Macro Aggregated
POP Begin: 10-01-2023 POP End: 09-30-2024
150.00
| __________________ |
| __________________ |
Tc-99m Medronate
POP Begin: 10-01-2023 POP End: 09-30-2024
65.00
| __________________ |
| __________________ |
Tc-99m Mebrofenin
POP Begin: 10-01-2023 POP End: 09-30-2024
20.00
| __________________ |
| __________________ |
Tc-99m Mertiatide
POP Begin: 10-01-2023 POP End: 09-30-2024
1.00
| __________________ |
| __________________ |
Tc-99m Bicisate
POP Begin: 10-01-2023 POP End: 09-30-2024
10.00
| __________________ |
| __________________ |
Tc-99m NaTcO4 Unit Dose
POP Begin: 10-01-2023 POP End: 09-30-2024
1.00
| __________________ |
| __________________ |
Tc-99m NaTcO4 Multi Dose
POP Begin: 10-01-2023 POP End: 09-30-2024
70.00
| __________________ |
| __________________ |
Tc-99m Sulfur Colloid
POP Begin: 10-01-2023 POP End: 09-30-2024
4.00
| __________________ |
| __________________ |
Tc-99m Filtered Sulfur Colloid
POP Begin: 10-01-2023 POP End: 09-30-2024
1.00
| __________________ |
| __________________ |
Tc-99m Pyrophosphate UD - Dose up to 30mCi
POP Begin: 10-01-2023 POP End: 09-30-2024
1.00
| __________________ |
| __________________ |
Tc-99m Exametazime UD - Dose up to 30mCi
POP Begin: 10-01-2023 POP End: 09-30-2024
2.00
| __________________ |
| __________________ |
Tc-99m Exametazime WBC's - Dose up to 25mCi
POP Begin: 10-01-2023 POP End: 09-30-2024
15.00
| __________________ |
| __________________ |
Tc-99m Cardioloite UD - Dose up to 30mCi
POP Begin: 10-01-2023 POP End: 09-30-2024
2.00
| __________________ |
| __________________ |
Tc-99m Succimer UD
POP Begin: 10-01-2023 POP End: 09-30-2024
30.00
| __________________ |
| __________________ |
I-123 USP NaI 200 uCi Cap
POP Begin: 10-01-2023 POP End: 09-30-2024
1.00
| __________________ |
| __________________ |
I-123 USP Nal Sol - Dose up to 30mCi
POP Begin: 10-01-2023 POP End: 09-30-2024
1.00
| __________________ |
| __________________ |
I-123 Iobenguane Sulfate UD - Dose
POP Begin: 10-01-2023 POP End: 09-30-2024
1.00
| __________________ |
| __________________ |
I-131 Drax DX/TX Capsule 1-6 mCi
POP Begin: 10-01-2023 POP End: 09-30-2024
35.00
| __________________ |
| __________________ |
I-131 Drax DX/TX Capsule each add'l mCi
POP Begin: 10-01-2023 POP End: 09-30-2024
1.00
| __________________ |
| __________________ |
In-111 Pentetreotide
POP Begin: 10-01-2023 POP End: 09-30-2024
2.00
| __________________ |
| __________________ |
In-111 Autologous WBC Suspension - Dose up to 500uCi
POP Begin: 10-01-2023 POP End: 09-30-2024
10.00
| __________________ |
| __________________ |
Ultra Tag RBC
POP Begin: 10-01-2023 POP End: 09-30-2024
3.00
| __________________ |
| __________________ |
Sincalided Unit Dose
POP Begin: 10-01-2023 POP End: 09-30-2024
6.00
| __________________ |
| __________________ |
F-18 FDG Unit Dose 0-15 mCi
POP Begin: 10-01-2023 POP End: 09-30-2024
450.00
| __________________ |
| __________________ |
F-18 FDG UD Source
POP Begin: 10-01-2023 POP End: 09-30-2024
1.00
| __________________ |
| __________________ |
F-18 NaF UD
POP Begin: 10-01-2023 POP End: 09-30-2024
3.00
| __________________ |
| __________________ |
Computer Software Fee
POP Begin: 10-01-2023 POP End: 09-30-2024
1.00
| __________________ |
| __________________ |
Computer Software Training Fee - Per Site (one time charge plus any additional required for future software updates)
POP Begin: 10-01-2023 POP End: 09-30-2024
4.00
| __________________ |
| __________________ |
Quarterly Audits - 1 location (Omaha)
POP Begin: 10-01-2023 POP End: 09-30-2024
260.00
| __________________ |
| __________________ |
Daily Delivery Fee
POP Begin: 10-01-2023 POP End: 09-30-2024
5.00
| __________________ |
| __________________ |
Pharmacist After Hours Callout
POP Begin: 10-01-2023 POP End: 09-30-2024
10.00
| __________________ |
| __________________ |
STAT Delivery
POP Begin: 10-01-2023 POP End: 09-30-2024
1.00
| __________________ |
| __________________ |
GA-67 Gallium Citrate UD - per mCi
POP Begin: 10-01-2023 POP End: 09-30-2024
20.00
| __________________ |
| __________________ |
Lymphoseek Study Dose - per patient
POP Begin: 10-01-2023 POP End: 09-30-2024
100.00
| __________________ |
| __________________ |
GA-68 PMSA
POP Begin: 10-01-2023 POP End: 09-30-2024
15.00
| __________________ |
| __________________ |
Tc-99m Sestamibi, generic Contract Period: Option 4 POP Begin: 10-01-2024 POP End: 09-30-2025
932.00
| __________________ |
| __________________ |
Tc-99m Tetrofosmin
POP Begin: 10-01-2024 POP End: 09-30-2025
1.00
| __________________ |
| __________________ |
Thallous Chloride
POP Begin: 10-01-2024 POP End: 09-30-2025
1.00
| __________________ |
| __________________ |
Tc-99m Exametazime Brain
POP Begin: 10-01-2024 POP End: 09-30-2025
8.00
| __________________ |
| __________________ |
Tc-99m Pentetate Aerosol
POP Begin: 10-01-2024 POP End: 09-30-2025
15.00
| __________________ |
| __________________ |
Tc-99 Macro Aggregated
POP Begin: 10-01-2024 POP End: 09-30-2025
150.00
| __________________ |
| __________________ |
Tc-99m Medronate
POP Begin: 10-01-2024 POP End: 09-30-2025
65.00
| __________________ |
| __________________ |
Tc-99m Mebrofenin
POP Begin: 10-01-2024 POP End: 09-30-2025
20.00
| __________________ |
| __________________ |
Tc-99m Mertiatide
POP Begin: 10-01-2024 POP End: 09-30-2025
1.00
| __________________ |
| __________________ |
Tc-99m Bicisate
POP Begin: 10-01-2024 POP End: 09-30-2025
10.00
| __________________ |
| __________________ |
Tc-99m NaTcO4 Unit Dose
POP Begin: 10-01-2024 POP End: 09-30-2025
1.00
| __________________ |
| __________________ |
Tc-99m NaTcO4 Multi Dose
POP Begin: 10-01-2024 POP End: 09-30-2025
70.00
| __________________ |
| __________________ |
Tc-99m Sulfur Colloid
POP Begin: 10-01-2024 POP End: 09-30-2025
4.00
| __________________ |
| __________________ |
Tc-99m Filtered Sulfur Colloid
POP Begin: 10-01-2024 POP End: 09-30-2025
1.00
| __________________ |
| __________________ |
Tc-99m Pyrophosphate UD - Dose up to 30mCi
POP Begin: 10-01-2024 POP End: 09-30-2025
1.00
| __________________ |
| __________________ |
Tc-99m Exametazime UD - Dose up to 30mCi
POP Begin: 10-01-2024 POP End: 09-30-2025
2.00
| __________________ |
| __________________ |
Tc-99m Exametazime WBC's - Dose up to 25mCi
POP Begin: 10-01-2024 POP End: 09-30-2025
15.00
| __________________ |
| __________________ |
Tc-99m Cardioloite UD - Dose up to 30mCi
POP Begin: 10-01-2024 POP End: 09-30-2025
2.00
| __________________ |
| __________________ |
Tc-99m Succimer UD
POP Begin: 10-01-2024 POP End: 09-30-2025
30.00
| __________________ |
| __________________ |
I-123 USP NaI 200 uCi Cap
POP Begin: 10-01-2024 POP End: 09-30-2025
1.00
| __________________ |
| __________________ |
I-123 USP Nal Sol - Dose up to 30mCi
POP Begin: 10-01-2024 POP End: 09-30-2025
1.00
| __________________ |
| __________________ |
I-123 Iobenguane Sulfate UD - Dose
POP Begin: 10-01-2024 POP End: 09-30-2025
1.00
| __________________ |
| __________________ |
I-131 Drax DX/TX Capsule 1-6 mCi
POP Begin: 10-01-2024 POP End: 09-30-2025
35.00
| __________________ |
| __________________ |
I-131 Drax DX/TX Capsule each add'l mCi
POP Begin: 10-01-2024 POP End: 09-30-2025
1.00
| __________________ |
| __________________ |
In-111 Pentetreotide
POP Begin: 10-01-2024 POP End: 09-30-2025
2.00
| __________________ |
| __________________ |
In-111 Autologous WBC Suspension - Dose up to 500uCi
POP Begin: 10-01-2024 POP End: 09-30-2025
10.00
| __________________ |
| __________________ |
Ultra Tag RBC
POP Begin: 10-01-2024 POP End: 09-30-2025
3.00
| __________________ |
| __________________ |
Sincalided Unit Dose
POP Begin: 10-01-2024 POP End: 09-30-2025
6.00
| __________________ |
| __________________ |
F-18 FDG Unit Dose 0-15 mCi
POP Begin: 10-01-2024 POP End: 09-30-2025
450.00
| __________________ |
| __________________ |
F-18 FDG UD Source
POP Begin: 10-01-2024 POP End: 09-30-2025
1.00
| __________________ |
| __________________ |
F-18 NaF UD
POP Begin: 10-01-2024 POP End: 09-30-2025
3.00
| __________________ |
| __________________ |
Computer Software Fee
POP Begin: 10-01-2024 POP End: 09-30-2025
1.00
| __________________ |
| __________________ |
Computer Software Training Fee - Per Site (one time charge plus any additional required for future software updates)
POP Begin: 10-01-2024 POP End: 09-30-2025
4.00
| __________________ |
| __________________ |
Quarterly Audits - 1 location (Omaha)
POP Begin: 10-01-2024 POP End: 09-30-2025
260.00
| __________________ |
| __________________ |
Daily Delivery Fee
POP Begin: 10-01-2024 POP End: 09-30-2025
5.00
| __________________ |
| __________________ |
Pharmacist After Hours Callout
POP Begin: 10-01-2024 POP End: 09-30-2025
10.00
| __________________ |
| __________________ |
STAT Delivery
POP Begin: 10-01-2024 POP End: 09-30-2025
1.00
| __________________ |
| __________________ |
GA-67 Gallium Citrate UD - per mCi
POP Begin: 10-01-2024 POP End: 09-30-2025
20.00
| __________________ |
| __________________ |
Lymphoseek Study Dose - per patient
POP Begin: 10-01-2024 POP End: 09-30-2025
100.00
| __________________ |
| __________________ |
GA-68 PMSA
POP Begin: 10-01-2024 POP End: 09-30-2025
15.00
| __________________ |
| __________________ |
Tc-99m Sestamibi, generic Contract Period: Option 5 POP Begin: 10-01-2025 POP End: 09-30-2026
932.00
| __________________ |
| __________________ |
Tc-99m Tetrofosmin
POP Begin: 10-01-2025 POP End: 09-30-2026
1.00
| __________________ |
| __________________ |
Thallous Chloride
POP Begin: 10-01-2025 POP End: 09-30-2026
1.00
| __________________ |
| __________________ |
Tc-99m Exametazime Brain
POP Begin: 10-01-2025 POP End: 09-30-2026
8.00
| __________________ |
| __________________ |
Tc-99m Pentetate Aerosol
POP Begin: 10-01-2025 POP End: 09-30-2026
15.00
| __________________ |
| __________________ |
Tc-99 Macro Aggregated
POP Begin: 10-01-2025 POP End: 09-30-2026
150.00
| __________________ |
| __________________ |
Tc-99m Medronate
POP Begin: 10-01-2025 POP End: 09-30-2026
65.00
| __________________ |
| __________________ |
Tc-99m Mebrofenin
POP Begin: 10-01-2025 POP End: 09-30-2026
20.00
| __________________ |
| __________________ |
Tc-99m Mertiatide
POP Begin: 10-01-2025 POP End: 09-30-2026
1.00
| __________________ |
| __________________ |
Tc-99m Bicisate
POP Begin: 10-01-2025 POP End: 09-30-2026
10.00
| __________________ |
| __________________ |
Tc-99m NaTcO4 Unit Dose
POP Begin: 10-01-2025 POP End: 09-30-2026
1.00
| __________________ |
| __________________ |
Tc-99m NaTcO4 Multi Dose
POP Begin: 10-01-2025 POP End: 09-30-2026
70.00
| __________________ |
| __________________ |
Tc-99m Sulfur Colloid
POP Begin: 10-01-2025 POP End: 09-30-2026
4.00
| __________________ |
| __________________ |
Tc-99m Filtered Sulfur Colloid
POP Begin: 10-01-2025 POP End: 09-30-2026
1.00
| __________________ |
| __________________ |
Tc-99m Pyrophosphate UD - Dose up to 30mCi
POP Begin: 10-01-2025 POP End: 09-30-2026
1.00
| __________________ |
| __________________ |
Tc-99m Exametazime UD - Dose up to 30mCi
POP Begin: 10-01-2025 POP End: 09-30-2026
2.00
| __________________ |
| __________________ |
Tc-99m Exametazime WBC's - Dose up to 25mCi
POP Begin: 10-01-2025 POP End: 09-30-2026
15.00
| __________________ |
| __________________ |
Tc-99m Cardioloite UD - Dose up to 30mCi
POP Begin: 10-01-2025 POP End: 09-30-2026
2.00
| __________________ |
| __________________ |
Tc-99m Succimer UD
POP Begin: 10-01-2025 POP End: 09-30-2026
30.00
| __________________ |
| __________________ |
I-123 USP NaI 200 uCi Cap
POP Begin: 10-01-2025 POP End: 09-30-2026
1.00
| __________________ |
| __________________ |
I-123 USP Nal Sol - Dose up to 30mCi
POP Begin: 10-01-2025 POP End: 09-30-2026
1.00
| __________________ |
| __________________ |
I-123 Iobenguane Sulfate UD - Dose
POP Begin: 10-01-2025 POP End: 09-30-2026
1.00
| __________________ |
| __________________ |
I-131 Drax DX/TX Capsule 1-6 mCi
POP Begin: 10-01-2025 POP End: 09-30-2026
35.00
| __________________ |
| __________________ |
I-131 Drax DX/TX Capsule each add'l mCi
POP Begin: 10-01-2025 POP End: 09-30-2026
1.00
| __________________ |
| __________________ |
In-111 Pentetreotide
POP Begin: 10-01-2025 POP End: 09-30-2026
2.00
| __________________ |
| __________________ |
In-111 Autologous WBC Suspension - Dose up to 500uCi
POP Begin: 10-01-2025 POP End: 09-30-2026
10.00
| __________________ |
| __________________ |
Ultra Tag RBC
POP Begin: 10-01-2025 POP End: 09-30-2026
3.00
| __________________ |
| __________________ |
Sincalided Unit Dose
POP Begin: 10-01-2025 POP End: 09-30-2026
6.00
| __________________ |
| __________________ |
F-18 FDG Unit Dose 0-15 mCi
POP Begin: 10-01-2025 POP End: 09-30-2026
450.00
| __________________ |
| __________________ |
F-18 FDG UD Source
POP Begin: 10-01-2025 POP End: 09-30-2026
1.00
| __________________ |
| __________________ |
F-18 NaF UD
POP Begin: 10-01-2025 POP End: 09-30-2026
3.00
| __________________ |
| __________________ |
Computer Software Fee
POP Begin: 10-01-2025 POP End: 09-30-2026
1.00
| __________________ |
| __________________ |
Computer Software Training Fee - Per Site (one time charge plus any additional required for future software updates)
POP Begin: 10-01-2025 POP End: 09-30-2026
4.00
| __________________ |
| __________________ |
Quarterly Audits - 1 location (Omaha)
POP Begin: 10-01-2025 POP End: 09-30-2026
260.00
| __________________ |
| __________________ |
Daily Delivery Fee
POP Begin: 10-01-2025 POP End: 09-30-2026
5.00
| __________________ |
| __________________ |
Pharmacist After Hours Callout
POP Begin: 10-01-2025 POP End: 09-30-2026
10.00
| __________________ |
| __________________ |
STAT Delivery
POP Begin: 10-01-2025 POP End: 09-30-2026
1.00
| __________________ |
| __________________ |
GA-67 Gallium Citrate UD - per mCi
POP Begin: 10-01-2025 POP End: 09-30-2026
20.00
| __________________ |
| __________________ |
Lymphoseek Study Dose - per patient
POP Begin: 10-01-2025 POP End: 09-30-2026
100.00
| __________________ |
| __________________ |
GA-68 PMSA
POP Begin: 10-01-2025 POP End: 09-30-2026
4.00
| __________________ |
| __________________ |
Tc-99m Sestamibi, generic Contract Period: Option 6 POP Begin: 10-01-2026 POP End: 12-31-2026
233.00
| __________________ |
| __________________ |
Tc-99m Tetrofosmin
POP Begin: 10-01-2026 POP End: 12-31-2026
1.00
| __________________ |
| __________________ |
Thallous Chloride
POP Begin: 10-01-2026 POP End: 12-31-2026
1.00
| __________________ |
| __________________ |
Tc-99m Exametazime Brain
POP Begin: 10-01-2026 POP End: 12-31-2026
2.00
| __________________ |
| __________________ |
Tc-99m Pentetate Aerosol
POP Begin: 10-01-2026 POP End: 12-31-2026
4.00
| __________________ |
| __________________ |
Tc-99 Macro Aggregated
POP Begin: 10-01-2026 POP End: 12-31-2026
38.00
| __________________ |
| __________________ |
Tc-99m Medronate
POP Begin: 10-01-2026 POP End: 12-31-2026
16.00
| __________________ |
| __________________ |
Tc-99m Mebrofenin
POP Begin: 10-01-2026 POP End: 12-31-2026
5.00
| __________________ |
| __________________ |
Tc-99m Mertiatide
POP Begin: 10-01-2026 POP End: 12-31-2026
1.00
| __________________ |
| __________________ |
Tc-99m Bicisate
POP Begin: 10-01-2026 POP End: 12-31-2026
3.00
| __________________ |
| __________________ |
Tc-99m NaTcO4 Unit Dose
POP Begin: 10-01-2026 POP End: 12-31-2026
1.00
| __________________ |
| __________________ |
Tc-99m NaTcO4 Multi Dose
POP Begin: 10-01-2026 POP End: 12-31-2026
18.00
| __________________ |
| __________________ |
Tc-99m Sulfur Colloid
POP Begin: 10-01-2026 POP End: 12-31-2026
1.00
| __________________ |
| __________________ |
Tc-99m Filtered Sulfur Colloid
POP Begin: 10-01-2026 POP End: 12-31-2026
1.00
| __________________ |
| __________________ |
Tc-99m Pyrophosphate UD - Dose up to 30mCi
POP Begin: 10-01-2026 POP End: 12-31-2026
1.00
| __________________ |
| __________________ |
Tc-99m Exametazime UD - Dose up to 30mCi
POP Begin: 10-01-2026 POP End: 12-31-2026
1.00
| __________________ |
| __________________ |
Tc-99m Exametazime WBC's - Dose up to 25mCi
POP Begin: 10-01-2026 POP End: 12-31-2026
4.00
| __________________ |
| __________________ |
Tc-99m Cardioloite UD - Dose up to 30mCi
POP Begin: 10-01-2026 POP End: 12-31-2026
1.00
| __________________ |
| __________________ |
Tc-99m Succimer UD
POP Begin: 10-01-2026 POP End: 12-31-2026
8.00
| __________________ |
| __________________ |
I-123 USP NaI 200 uCi Cap
POP Begin: 10-01-2026 POP End: 12-31-2026
1.00
| __________________ |
| __________________ |
I-123 USP Nal Sol - Dose up to 30mCi
POP Begin: 10-01-2026 POP End: 12-31-2026
1.00
| __________________ |
| __________________ |
I-123 Iobenguane Sulfate UD - Dose
POP Begin: 10-01-2026 POP End: 12-31-2026
1.00
| __________________ |
| __________________ |
I-131 Drax DX/TX Capsule 1-6 mCi
POP Begin: 10-01-2026 POP End: 12-31-2026
9.00
| __________________ |
| __________________ |
I-131 Drax DX/TX Capsule each add'l mCi
POP Begin: 10-01-2026 POP End: 12-31-2026
1.00
| __________________ |
| __________________ |
In-111 Pentetreotide
POP Begin: 10-01-2026 POP End: 12-31-2026
1.00
| __________________ |
| __________________ |
In-111 Autologous WBC Suspension - Dose up to 500uCi
POP Begin: 10-01-2026 POP End: 12-31-2026
3.00
| __________________ |
| __________________ |
Ultra Tag RBC
POP Begin: 10-01-2026 POP End: 12-31-2026
1.00
| __________________ |
| __________________ |
Sincalided Unit Dose
POP Begin: 10-01-2026 POP End: 12-31-2026
2.00
| __________________ |
| __________________ |
F-18 FDG Unit Dose 0-15 mCi
POP Begin: 10-01-2026 POP End: 12-31-2026
113.00
| __________________ |
| __________________ |
F-18 FDG UD Source
POP Begin: 10-01-2026 POP End: 12-31-2026
1.00
| __________________ |
| __________________ |
F-18 NaF UD
POP Begin: 10-01-2026 POP End: 12-31-2026
1.00
| __________________ |
| __________________ |
Computer Software Fee
POP Begin: 10-01-2026 POP End: 12-31-2026
1.00
| __________________ |
| __________________ |
Computer Software Training Fee - Per Site (one time charge plus any additional required for future software updates)
POP Begin: 10-01-2026 POP End: 12-31-2026
1.00
| __________________ |
| __________________ |
Quarterly Audits - 1 location (Omaha)
POP Begin: 10-01-2026 POP End: 12-31-2026
65.00
| __________________ |
| __________________ |
Daily Delivery Fee
POP Begin: 10-01-2026 POP End: 12-31-2026
1.00
| __________________ |
| __________________ |
Pharmacist After Hours Callout
POP Begin: 10-01-2026 POP End: 12-31-2026
3.00
| __________________ |
| __________________ |
STAT Delivery
POP Begin: 10-01-2026 POP End: 12-31-2026
1.00
| __________________ |
| __________________ |
GA-67 Gallium Citrate UD - per mCi
POP Begin: 10-01-2026 POP End: 12-31-2026
5.00
| __________________ |
| __________________ |
Lymphoseek Study Dose - per patient
POP Begin: 10-01-2026 POP End: 12-31-2026
25.00
| __________________ |
| __________________ |
GA-68 PMSA
POP Begin: 10-01-2026 POP End: 12-31-2026
| GRAND TOTAL |
| __________________ |
Indefinite Delivery Indefinite Quantity (IDIQ) Ceiling Limitation and Minimum Guarantee
The Department of Veterans Affairs has set the ceiling limitation for this Indefinite Delivery Indefinite Quantity (IDIQ) contract at $3,000,000.00 for the lifetime of this contract. The total cost of all orders placed against this contract will not exceed this ceiling.
The minimum guaranteed is set at $100,000.00 for the lifetime of this contract.
**Note on the Price/Cost Schedule
36C26322Q0059 In order to comply with the VA’s Supply Chain Master Catalog, the above Price/Cost Schedule utilizes Option 1-6, as this is fixed value within the system that is not editable. The government is utilizing Option 1-6 for this reason only, and this contract will utilize ordering period 1-6 in lieu of options.
B.3 STATEMENT OF WORK
NWIHCS NUCMED Radiopharmaceuticals
The purpose of this contract is to provide Nebraska-Western Iowa Health Care System, Omaha location, with radiopharmaceutical agents and provide the delivery of those agents. Exact delivery address is:
| FACILITY |
| LOCATION |
| Omaha VA Medical Center |
| Omaha VA Medical Center |
Nuclear Medicine Department, 2nd Floor, Rom 2036 4101 Woolworth Avenue, Omaha, NE 68105
1. GENERAL:
1.1. For routine orders: Placed and delivered Monday through Friday between the hours of 7:00 a.m. to 4:00 p.m., delivery shall be made within 24 hours after receipt of telephone or web-based order, and in consideration of calibration times as stated in such orders.
1.2. Emergency weekday orders placed between the hours of 7:00 a.m. to 4:00 p.m. Monday through Friday shall be delivered within 60 minutes after receipt of telephone order or web-based order.
1.3. Emergency orders placed weeknights, weekends and holidays shall be delivered within 2 ½ hours after the vendor’s receipt of the telephone order.
1.4. Deliveries/On-site Audits: Contractor will be required to create a Reptrax account (www.reptrax.com). Contract personnel must sign in and out for each visit at the Reptrax kiosk and wear the photo identification on outermost garment the entire time on property. In the event a kiosk is not available, contract personnel will be required to check in with the VA Police office and obtain a contractor’s badge.
1.4.1. It is the responsibility of the contractor to park in the appropriate designated parking areas. Information on parking is available from the VA Police. The VA will not invalidate or make reimbursement for parking violations of the contractor under any conditions.
1.4.2. All vehicles will be locked and the keys removed while performing service on the VA’s property. This is intended to protect the contractor's property and provide for the safety of the VA’s personnel. Vehicle(s) shall be identified. Parking in the appropriate designated parking areas is expected.
1.5. The Federal Holidays (actual days observed by the Federal Government) are:
New Year’s Day Martin Luther King’s Birthday Washington’s Birthday Memorial Day Independence Day Labor Day Columbus Day Veterans Day Thanksgiving Day Christmas Day Any day specifically declared by the President of the United States to be a national holiday.
2. REQUIREMENTS:
2.1. Contractor must be licensed to receive, possess, and distribute radioactive material by the State of Nebraska as well as the Nuclear Regulatory Commission and be regularly established in the business of providing radiopharmaceuticals. Offeror must provide copies of these licenses and certifications along with technical proposal to the Contracting Officer. Any changes made to the Contractor license(s) must be forwarded within 30 days of all amendments and/or renewals.
2.2. All products provided under this contract shall meet all requirements of the Nuclear Regulatory Commission as well as pertinent State requirements. All products provided under this contract shall be packaged and shipped in accordance with the requirements of the Nuclear Regulatory Commission (NRC), Department of Transportation (DOT), as well as any other applicable agencies such as the Food and Drug Administration (FDA). All products returned will also be packaged in accordance with the requirements of the NRC and the DOT.
2.3. All products provided under this contract shall be in compliance with all OSHA manufacturing, packaging and shipping regulations. Furthermore, all products provided under this contract shall be in compliance with enforceable standards associated with the FDA and United States Pharmacopeia (USP).
2.4. The contractor shall guarantee the quality of all radiopharmaceuticals. Quality control shall include percent tag and 99Mo breakthrough as appropriate per 10 CFR 35.204(a)(1) or applicable agreement state requirements. The contractor shall provide quality control on each agent dispensed. The contractor shall guarantee the quality of all radiopharmaceuticals.
2.5. The contractor shall provide 24-hour on-call service for emergency procedures.
2.6. The contractor shall be capable of providing the radiopharmaceuticals and estimated quantities necessary to provide operation levels. Types and quantities of product may change throughout the course of the contract and may vary with the utilization of PET/CT studies.
2.7. Contractor/supplier shall abide by (CFR 10) Title 10 Code of Federal Regulations, which states: Title 10 Code of Federal Regulations is available at: http://www.nrc.gov/reading-rm/doc-collections/cfr/. A licensee may use for medical use only:
2.7.1. Byproduct material manufactured, labeled, packaged, and distributed in accordance with a license issues pursuant to the regulations in Title 10, Code of Federal Regulations, part 30 and SS32.72, or 32.74 of this chapter or the equivalent regulations of an Agreement State:
2.7.2. Reagent kits that have been manufactured, labeled, packed, and distributed in accordance with the approval by the Commission pursuant to S32.72 or an Agreement State under equivalent regulations for the preparation of radiopharmaceuticals for medical use.
2.8. Items must be adequately packaged to prevent damage during handling and storage and, such packages must meet regulatory standards associated with 49 CFR 172-175. All packaging and labeling must meet all federal and state regulations. All packaging of radioactive material MUST BE clearly labeled RADIOACTIVE on the outside of the carton in which it is shipped.
2.9. Contractor must provide a copy of their radio-pharmacy laboratory’s current quality control manual and must be willing to discuss any discrepancies in lab results, which do not fit the clinical picture. This is to be provided on a quarterly basis upon request from the VA Nuclear Medicine POC.
2.10. Contractor must test all products for Quality Control periodically and only those products that pass quality control may be sent to the VA. This testing shall be performed at no cost to the VA. The contractor will provide a detailed description of the test upon request from the VA Nuclear Medicine POC.
2.11. Contractor must assign to this medical center an individual sales representative to aide in facilitation in the smooth coordination between the medical center and laboratory pharmacy.
2.12. Contractor must replace any expired cold kits prior to its expiration date at no charge. The NWI VA Nuclear Medicine Staff will give the Contractor 10 day’s prior notice. All cold kit prescription drug vials being returned to the contractor because of short expiration dating must be accompanied by documentation demonstrating that the drugs in question have been stored in temperature environments as recommended by the drug manufacturers.
2.13. Contractor must provide current material safety data sheets and update as necessary for all delivered products or the contractor must provide their website link where MSDS and package inserts for all radiopharmaceuticals can be read and printed.
2.14. Contractor must provide patient orientation education video presentations and/or other appropriate material as deemed necessary by the medical center. If provided this will be provided at no expense to the government.
2.15. Contractor may provide appropriate signs and posters alerting patients, employees and the public, of safety precautions in handling of radioactive materials.
2.16. Contractor must replace any items delivered in error at no cost to the medical center.
2.17. Contractor must label all products with the following information:
· Prescribed radiopharmaceutical,
· Activity of radiopharmaceutical,
· Calibration time,
· Radiopharmaceutical expiration time and date
· any other pertinent information deemed necessary per regulation
2.18. Contractor must follow all pertinent United States Pharmacopeia 795 “Pharmaceutical Compounding – Nonsterile Preparations”, USP 797 “Pharmaceutical Compounding –Sterile Preparations”, and USP 825 “Radiopharmaceuticals – Preparation, Compounding, Dispensing, and Repackaging” guidelines and provide verification of compliance upon Contracting Officer request.
2.19. No Employee status: The contractor shall be responsible for protecting the contractor’s staff furnishing services. To carry out this responsibility, the contractor shall provide or certify that the following are provided for all of their staff providing services under the resultant contract:
| • | Workers’ compensation |
| • | Professional liability insurance |
| • | Health examinations |
| • | Income tax withholding, and |
| • | FICA and Medicare tax withholding |
2.20. TRANSPORTATION: Contractor personnel, drivers, and alternates, shall be able to read, write, speak, and understand the English language. Personnel shall present a professional appearance and be easily recognized as a contract employee by wearing an identification badge that includes the company’s name/logo, employee name, and photograph. Vehicles used in the course of this service shall prominently display the company’s name/logo.
2.20.1. Contractor must ensure that courier service/drivers maintain their Motor Carrier Permit, hazardous material license number, certificate of training of couriers (employees), valid state-issued drivers’ licenses, vehicle insurance and registration.
2.20.2. The contractor shall be required to maintain a record log of courier deliveries, indicating time and date, number, and description of items being delivered, and delivery signature(s).
2.20.3. The contractor will be responsible for all reimbursement of the original and/or repeat items resulting from mishandling or loss.
2.20.4. All vehicles are to be insured in accordance with the regulations of the State of Nebraska at the expense of the contractor.
3. COMPUTER:
3.1. The contractor will provide a computer system, to be returned at the end of contract term including any option years exercised, (hardware and software) for dose tracking incoming and outgoing inventories, radioactive isotope sources, wastes, etc., to remain in compliance with the NRC and the proper tracking and disposal of isotopes. The computer system will provide record keeping for the Nuclear Medicine department for surveys, swipes, and personal surveys to remain compliant with regulations required by the NRC. Contractor will provide computer system training to VA staff and such training will be billed as a one-time charge. Contractor will provide hardware & software updates and future training at no further charge to the Government.
4. BILLING/INVOICES:
4.1. Contractor must submit a monthly invoice in arrears. The invoices shall contain the following information at a minimum:
4.1.1.1. Period covered
4.1.1.2. Billing date
4.1.1.3. Contract Number
4.1.1.4. Purchase Order Number
4.1.1.5. Name of Radiopharmaceutical agent
4.1.1.6. Quantity of agent
4.1.1.7. Unit cost
4.1.1.8. Total price
4.2. Contractor shall add to the invoice the cost of overages. Any cost to replace damaged or incorrect products will be at the cost of the contractor. Replacements must be received within 48 hours of notification by the VA.
4.3. Billings rendered by the contractor to the NWI VA Health Care System for services furnished under the terms of this contract shall be billed in full. Neither beneficiary, his/her insurer, nor any other third party shall be billed.
4.4. Payments for services will be at the rates specified in the Schedule of Supplies/Services.
4.5. Payment shall only be made for actual services rendered.
4.6. Vendor Electronic Invoice Submission Methods: Facsimile, e-mail, and scanned documents are not acceptable forms of submission for payment requests. Electronic form means an automated system transmitting information electronically according to the accepted electronic data transmission methods below. Reference VAAR Clause 852.232-72: The contractor shall submit electronic payment requests through:
4.6.1. VA’s Electronic Invoice Presentment and Payment System (See Web site at http://www.fsc.va.gov/einvoice.asp.); or,
4.6.2. A system that conforms to the X12 electronic data interchange (EDI) formats established by the Accredited Standards Center (ASC) chartered by the American National Standards Institute (ANSI). The X12 EDI Web site (http://www.x12.org) includes additional information on EDI 810 and 811 formats.
4.6.3. The Contract may contact Financial Service Center (FSC) at the phone number or email address listed below with any questions about the e-invoicing program:
4.6.3.1. Tungsten e-Invoice Setup Information: 1-877-489-6135
4.6.3.2. Tungsten e-Invoice email: VA.Registration@Tungsten-Network.com
4.6.3.3. FSC e-Invoice Contact Information: 1-877-353-9791
4.6.3.4. FSC e-invoice email: vafsccshd@va.gov
SECTION C - CONTRACT CLAUSES
ADDENDUM to FAR 52.212-4 CONTRACT TERMS AND CONDITIONS—COMMERCIAL ITEMS Clauses that are incorporated by reference (by Citation Number, Title, and Date), have the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available.
The following clauses are incorporated into 52.212-4 as an addendum to this contract:
C.1 52.252-2 CLAUSES INCORPORATED BY REFERENCE (FEB 1998)
This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this/these address(es):
http://www.acquisition.gov/far/index.html http://www.va.gov/oal/library/vaar/
(End of Clause)
| FAR Number |
| Title |
| Date |
| 52.203-17 |
| CONTRACTOR EMPLOYEE WHISTLEBLOWER RIGHTS AND REQUIREMENT TO INFORM EMPLOYEES OF WHISTLEBLOWER RIGHTS |
| JUN 2020 |
| 52.204-4 |
| PRINTED OR COPIED DOUBLE-SIDED ON POSTCONSUMER FIBER CONTENT PAPER |
| MAY 2011 |
| 52.204-13 |
| SYSTEM FOR AWARD MANAGEMENT MAINTENANCE |
| OCT 2018 |
| 52.204-18 |
| COMMERCIAL AND GOVERNMENT ENTITY CODE MAINTENANCE |
| AUG 2020 |
| 52.232-40 |
| PROVIDING ACCELERATED PAYMENTS TO SMALL BUSINESS SUBCONTRACTORS |
| DEC 2013 |
C.2 52.216-18 ORDERING (AUG 2020)
(a) Any supplies and services to be furnished under this contract shall be ordered by issuance of delivery orders or task orders by the individuals or activities designated in the Schedule. Such orders may be issued from the effective date through end of the effective period.
(b) All delivery orders or task orders are subject to the terms and conditions of this contract. In the event of conflict between a delivery order or task order and this contract, the contract shall control.
(c) A delivery order or task order is considered "issued" when—
(1) If sent by mail (includes transmittal by U.S. mail or private delivery service), the Government deposits the order in the mail;
(2) If sent by fax, the Government transmits the order to the Contractor’s fax number; or
(3) If sent electronically, the Government either—
(i) Posts a copy of the delivery order or task order to a Government document access system, and notice is sent to the Contractor; or
(ii) Distributes the delivery order or task order via email to the Contractor’s email address.
(d) Orders may be issued by methods other than those enumerated in this clause only if authorized in the contract.
(End of Clause)
C.3 52.216-19 ORDER LIMITATIONS (OCT 1995)
(a) Minimum order. When the Government requires supplies or services covered by this contract in an amount of less than $3,000.00, the Government is not obligated to purchase, nor is the Contractor obligated to furnish, those supplies or services under the contract.
(b) Maximum order. The Contractor is not obligated to honor—
(1) Any order for a single item in excess of $250,000.00;
(2) Any order for a combination of items in excess of $250,000.00; or
(3) A series of orders from the same ordering office within 30 calendar days that together call for quantities exceeding the limitation in paragraph (b)(1) or (2) of this section.
(c) If this is a requirements contract (i.e., includes the Requirements clause at subsection 52.216-21 of the Federal Acquisition Regulation (FAR)), the Government is not required to order a part of any one requirement from the Contractor if that requirement exceeds the maximum-order limitations in paragraph (b) of this section.
(d) Notwithstanding paragraphs (b) and (c) of this section, the Contractor shall honor any order exceeding the maximum order limitations in paragraph (b), unless that order (or orders) is returned to the ordering office within 2 calendar days after issuance, with written notice stating the Contractor's intent…
This is the start of the file's text. The full file is on GovTribe.
File details come from the government source that posted it. Updated .